Edgewise Therapeutics, Inc. ( EWTX) - Stock Earnings
EWTX Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 5, 2026, midnight | — / — | — | — / — | — |
EWTX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -50.2 million USD | — USD |
| 2026Q1 | -49.0 million USD | — USD |
| 2026Q2 | -57.3 million USD | — USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
EWTX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -100.2 million USD | — USD |
| 2024 | -133.8 million USD | — USD |
| 2025 | -167.8 million USD | — USD |
| 2026 Est. | — | — |
EWTX
Price: $38.01
52 week price:
Earnings Per Share: -1.84 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 74985
Market Capitalization: 4.5 billion